Patents by Inventor David Lawrence Becker

David Lawrence Becker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of ocular disorders with anti-connexin proteins and mimetics
    Patent number: 10201590
    Abstract: Methods and compositions for modulating the activities of connexins are provided, including, for example, for use for treatment of cardiovascular, vascular, neurological, for wounds and for other indications. These compounds and methods can be used therapeutically, for example, to reduce the severity of adverse effects associated diseases and disorders where localized disruption in direct cell-cell communication or prevention of hemichannel opening is desirable.
    Type: Grant
    Filed: February 1, 2016
    Date of Patent: February 12, 2019
    Assignee: OCUNEXUS THERAPEUTICS, INC.
    Inventors: Colin Richard Green, David Lawrence Becker
  • Formulations comprising antisense nucleotides to connexins
    Patent number: 9932592
    Abstract: A therapeutic and/or cosmetic formulation comprising at least one anti-sense polynucleotide to a connexin protein together with a pharmaceutically acceptable carrier or vehicle is useful in site specific down regulation of connexin protein expression, particularly in reduction of neuronal cells death, wound healing, reduction of inflammation, decrease of scar formation and skin rejuvenation and thickening.
    Type: Grant
    Filed: November 24, 2015
    Date of Patent: April 3, 2018
    Assignee: CoDa Therapeutics, Inc.
    Inventors: David Lawrence Becker, Colin Richard Green
  • Treatment of fibrotic conditions
    Patent number: 9738892
    Abstract: Treatment of fibrosis and fibrotic diseases, disorders, and conditions, and associated methods, compositions, formulations and articles.
    Type: Grant
    Filed: March 9, 2015
    Date of Patent: August 22, 2017
    Assignee: CODA THERAPEUTICS, INC.
    Inventors: David Lawrence Becker, Colin Richard Green, Bradford James Duft
  • Impaired wound healing compositions and treatments
    Patent number: 9637745
    Abstract: Connexin modulation for the treatment of wounds that do not heal at expected rates, including delayed healing wounds, incompletely healing wounds, and chronic wounds, and associated methods, compositions and articles.
    Type: Grant
    Filed: May 11, 2015
    Date of Patent: May 2, 2017
    Assignee: CoDa Therapeutics, Inc.
    Inventors: David Lawrence Becker, Colin Richard Green, Bradford James Duft
  • Medical devices
    Patent number: 9561311
    Abstract: Medical devices comprising an anti-connexin agent suitable for introduction into a subject.
    Type: Grant
    Filed: May 18, 2015
    Date of Patent: February 7, 2017
    Assignee: CoDA Therapeutics, Inc.
    Inventors: David Lawrence Becker, Colin Richard Green, Bradford James Duft
  • ANTI-CONNEXIN COMPOUNDS AND USES THEREOF
    Publication number: 20160331805
    Abstract: Methods and compositions for modulating the activities of connexins are provided, including, for example, for use for treatment of cardiovascular, vascular, neurological, for wounds and for other indications. These compounds and methods can be used therapeutically, for example, to reduce the severity of adverse effects associated diseases and disorders where localized disruption in direct cell-cell communication or prevention of hemichannel opening is desirable.
    Type: Application
    Filed: February 1, 2016
    Publication date: November 17, 2016
    Inventors: Colin Richard GREEN, David Lawrence BECKER
  • FORMULATIONS COMPRISING ANTISENSE NUCLEOTIDES TO CONNEXINS
    Publication number: 20160160214
    Abstract: A therapeutic and/or cosmetic formulation comprising at least one anti-sense polynucleotide to a connexin protein together with a pharmaceutically acceptable carrier or vehicle is useful in site specific down regulation of connexin protein expression, particularly in reduction of neuronal cells death, wound healing, reduction of inflammation, decrease of scar formation and skin rejuvenation and thickening.
    Type: Application
    Filed: November 24, 2015
    Publication date: June 9, 2016
    Inventors: David Lawrence Becker, Colin Richard Green
  • Formulations comprising antisense nucleotides to connexins
    Patent number: 9193754
    Abstract: A therapeutic and/or cosmetic formulation comprising at least one anti-sense polynucleotide to a connexin protein together with a pharmaceutically acceptable carrier or vehicle is useful in site specific down regulation of connexin protein expression, particularly in reduction of neuronal cells death, wound healing, reduction of inflammation, decrease of scar formation and skin rejuvenation and thickening.
    Type: Grant
    Filed: November 19, 2012
    Date of Patent: November 24, 2015
    Assignee: CoDa Therapeutics, Inc.
    Inventors: David Lawrence Becker, Colin Richard Green
  • IMPAIRED WOUND HEALING COMPOSITIONS AND TREATMENTS
    Publication number: 20150315598
    Abstract: Connexin modulation for the treatment of wounds that do not heal at expected rates, including delayed healing wounds, incompletely healing wounds, and chronic wounds, and associated methods, compositions and articles.
    Type: Application
    Filed: May 11, 2015
    Publication date: November 5, 2015
    Inventors: David Lawrence BECKER, Colin Richard GREEN, Bradford James DUFT
  • MEDICAL DEVICES
    Publication number: 20150297804
    Abstract: Medical devices comprising an anti-connexin agent suitable for introduction into a subject.
    Type: Application
    Filed: May 18, 2015
    Publication date: October 22, 2015
    Inventors: David Lawrence BECKER, Colin Richard GREEN, Bradford James DUFT
  • TREATMENT OF FIBROTIC CONDITIONS
    Publication number: 20150232842
    Abstract: Treatment of fibrosis and fibrotic diseases, disorders, and conditions, and associated methods, compositions, formulations and articles.
    Type: Application
    Filed: March 9, 2015
    Publication date: August 20, 2015
    Inventors: David Lawrence BECKER, Colin Richard GREEN, Bradford James DUFT
  • TREATMENT OF SURGICAL ADHESIONS
    Publication number: 20110144182
    Abstract: Connexin modulation for the treatment of surgical adhesions, and associated methods, compositions, and articles.
    Type: Application
    Filed: December 22, 2008
    Publication date: June 16, 2011
    Inventors: David Lawrence Becker, Colin Richard Green, Bradford James Duft
  • TREATMENT OF FIBROTIC CONDITIONS
    Publication number: 20110136890
    Abstract: Treatment of fibrosis and fibrotic diseases, disorders, and conditions, and associated methods, compositions, formulations and articles.
    Type: Application
    Filed: December 22, 2008
    Publication date: June 9, 2011
    Inventors: David Lawrence Becker, Colin Richard Green, Bradford James Duft
  • TREATMENT OF ABNORMAL OR EXCESSIVE SCARS
    Publication number: 20110130710
    Abstract: Methods, compounds, compositions, kits and articles of manufacture comprising anti-connexin polynucleotides for prevention and/or treatment of abnormal scars, including keloid scars, hypertrophic scars, atrophic scars, and widespread scars.
    Type: Application
    Filed: December 22, 2008
    Publication date: June 2, 2011
    Inventors: David Lawrence Becker, Colin Richard Green, Bradford James Duft